shan lii ching, ernieda hatah, farida islahudin, nurul ain mohd tahir, hui yin tay .  (2026).  dynamic medication challenges in hemodialysis: rethinking medication therapy management strategies through longitudinal trends.  - kidney medicine.  1 - 13. 

cheng jun chong, mohd makmor bakry, ernieda hatah, nor asyikin mohd tahir, norlaila mustafa.  (2025).  effects of mobile apps intervention on medication adherence and type 2 diabetes mellitus control: a systematic review and meta-analysis.  - journal of telemedicine and telecare.  157 - 173. 

cheng jun chong, mohd makmor-bakry, ernieda hatah, nor asyikin mohd tahir, norlaila mustafa, francis r. capule, andi hermansyah.  (2025).  a qualitative study of type 2 diabetes mellitus outpatients’ perspectives on readiness, acceptance and barriers of mobile apps for medication adherence.  - patient education and counseling.  1 - 8. 

ming chiang lim, ernieda hatah, jia ean goh, ahmad ramdani abd manan, joyce chu yee tan .  (2025).  validation and potential refinement of the malaysia medication adherence assessment tool (mymaat) among patients with non-dialysis chronic kidney disease.  - plos one.  1 - 18. 

farahwahida mohd kasim, ernieda hatah, lokhman hakim osman, adliah mhd ali, zaheer-ud-din babar.  (2024).  analyzing trends and factors influencing price changes in public pooled drugs procurement system in malaysia: exploring market competition.  - saudi pharmaceutical journal.  1 - 10. 

abdul hafeez ahmad hamdi, ernieda hatah, mohd makmor bakry, a halim basari, najwa ahmad hamdi.  (2024).  operations management of pharmaceutical supply during preparedness and disaster response: a scoping review.  - international journal of disaster risk reduction.  1-17. 

izzati yussof, nur faizah ab muin, masnizah mohd, ernieda hatah, nor asyikin mohd tahir, noraida mohamed shah.  (2023).  breast cancer prevention and treatment misinformation on twitter: an analysis of two languages.  - digital health.  1-11. 

maali mustafa, ernieda hatah, mohd makmor-bakry.  (2023).  perspectives of pharmacists on medication reviews- exploring implementation research in service establishment in community settings.  - research in social & administrative pharmacy.  673-680. 

izzati yussof, nor asyikin mohd tahir, ernieda hatah, noraida mohamed shah.  (2022).  factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review.  - the breast.  22-35. 

shamin mohd saffian, nor aini jamil, nor asyikin mohd tahir, ernieda hatah.  (2022).  vitamin d insufficiency is high in malaysia: a systematic review and meta-analysis of studies on vitamin d status in malaysia.  - frontiers in nutrition.  1-13. 

ming chiang lim, ernieda hatah, kay chee lai, asdayati buang, tze juin koay, wendy jia yii sim, suet chee ng.  (2022).  perceptions with type 2 diabetes mellitus of the value of prescribed medications among malaysian adults: a qualitative study.  - patient preference and adherence.  3133-3142. 

naeem mubarak, sarwat ali raja, asma sarwar khan, sabba kanwal, nasira saif-ur-rehman, muhammad majid aziz, irshad hussain, ernieda hatah, che suraya zin.  (2021).  a conceptual framework of the way forward to a community pharmacist-general practitioner collaborative medication therapy management model for chronic diseases in malaysian primary care: a qualitative.  - risk management and healthcare policy.  1615-1627. 

muhammad junaid farrukh, mohd makmor bakry, ernieda hatah, tan hui jan.  (2021).  medication adherence status among patients with neurological conditions and its association with quality of life.  - saudi pharmaceutical journal.  427-433. 

nur sufiza ahmad, ernieda hatah, mohamad ridha jalil, mohd makmor-bakry.  (2021).  consumers knowledge, attitudes and practices toward medicine price transparency at private healthcare setting in malaysia.  - frontiers in public health.  1-9. 

nur sufiza ahmad,mohd makmor-bakry, ernieda hatah.  (2020).  multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in malaysia.  - saudi pharmaceutical journal.  850-858. 

nur sufiza ahmad, mohd makmor-bakry, ernieda hatah.  (2020).  drug price transparency initiative: a scoping review.  - research in social and administrative pharmacy.  1359-1369. 

ernieda hatah, nadiah rahim, mohd makmor-bakry, noraida mohamed shah, noraini mohamad, mahadir ahmad, nor hasni haron, choe sze hwe, angeline tan meng wah, fahmi hassan, shakirin shaik rahmat, sarah ann robert, noraidatulakma abdullah.  (2020).  development and validation of malaysia medication adherence assessment tool (mymaat) for diabetic patients.  - plos one.  1-17. 

naeem mubarak , ernieda hatah , mohd aznan md aris , asrul akmal shafie , che suraya zin.  (2019).  consensus among healthcare stakeholders on a collaborative medication therapy management model for chronic diseases in malaysia; a delphi study.  - plos one.  1-28. 

muhammad junaid farrukh, mohd makmor-bakry, ernieda hatah, hui jan tan.  (2018).  use of complementary and alternative medicine and adherence to antiepileptic drug therapy among epilepsy patients: a systematic review.  - patient preference and adherence.  2111-2121. 

hamiza aziz, ernieda hatah, mohd makmor bakry, farida islahudin.  (2016).  how payment scheme affects patients` adherence to medications? a systematic review.  - patient preference and adherence.  837-850. 

irma wati ngadimon, farida islahudin, ernieda hatah, noraida mohamed shah, mohd makmor-bakry.  (2015).  antibiotic and shared decision-making preferences among adolescents in malaysia.  - patient preference and adherence.  665-673. 

ernieda hatah, kien ping lim, adliah mohd ali, noraida mohamed shah, farida islahudin.  (2015).  the influence of cultural and religious orientations on social support and its potential impact on medication adherence.  - patient preference and adherence.  589-596. 

ernieda hatah, rhiannon braund, june tordoff & stephen b. duffull.  (2014).  a systematic review and meta-analysis of pharmacist-led fee-for-services medication review.  - british journal of clinical pharmacology.  77(1):102-115.